Based on many years of research, TAVIPILOT is the first robotic solution developed using CARANX Medical’s AiiR platform to optimize aortic valve procedure.
TAVIPILOT is the first application of the Caranx medical AiiR platform that will enable a more precise aortic valve positioning, leading to reaching the level of experts.
New treatment paradigms are required to expand access to care for patients worldwide. Our ambition is to broaden the adoption of endoluminal techniques around the world, to enable access to less or non-invasive care for patients everywhere.
By combining 3 advanced technologies that enhance precision, patient-tailored solutions, and standardization, the AiiR platform enables intelligent robots to understand complex personalized anatomy and perform autonomous procedures under the supervision of the clinician.
The AIIR platform provides a highly differentiated solution, with integration of complex modalities:
AI trained on our own multi-modal database relying on several thousands of patients, allowing to build a digital twin able to anticipate potential complications and to make specific recommendations for a specific patient.
Real-time multi-modal medical image analysis allow fast and intelligent decision-making.
Autonomous motions supervised by the clinician allowing higher precision. The clinician can also teleoperate the robot with AI guidance at any stage.
Events
July 2025
Caranx Medical, specializing
in the development of an autonomous robot to democratize access to Transcatheter Aortic Valve
Implantation (TAVI), a lifesaving procedure, today announced FDA clearance for US commercialization of
the world first AI Software for real-time intra-operative guidance of transcatheter heart valve
implantation.
Read the full press release here: https://lnkd.in/ehwB-4NF
February 2025
Caranx Medical is honored to have been selected as a laureate for the 2025 « Innovation in Medical Imaging » initiative, part of France’s ambitious #France2030 plan. This national program aims to foster at least 20 groundbreaking projects across the biopharmaceutical and medical device sectors, ultimately strengthening France’s position as a global center of excellence in medical imaging.
We are immensely proud that our TaviPilot® AI Software, leveraging AI to deliver real-time augmented reality during TAVI procedures, has received this prestigious recognition.
This milestone represents a significant achievement for the Caranx Medical team and a major advancement for our startup. Through this initiative, we will benefit from substantial support provided by the French state under the #France2030 framework.
In total, nearly €54 billion will be strategically invested across France, ensuring the success of innovative enterprises, universities, and research institutions in key future-oriented sectors.
(The entirety of the measures of the plan France 2030, on france2030.gouv.fr)
January 2025: Caranx Medical announces FDA submission of TAVIPILOT Soft:
the world first AI Software for real-time intra-operative guidance of transcatheter heart valve implantation.
April 2024 – Caranx Medical, announced the successful world first robotic assisted heart valve (aortic valve) implantation in an animal.
The assisted heart valve implantation in the animal was successfully performed
by Dr. Stéphane Lopez, Dr. Eric Sejor, Caranx CTO Pierre Berthet-Rayne and Caranx team.
“This groundbreaking achievement is the result of hard teamwork. At Caranx Medical, we are dedicated to improving patients’ lives through true innovation. This successful transcatheter robotic aortic valve implantation marks the first step toward a new generation of intelligent robots guided by AI, set to transform healthcare as we know it” says Pierre Berthet-Rayne, PhD, co-founder and CTO of Caranx.
“This major medical first lies not only in the technical achievement of Caranx Medical’s engineers, but also in the impact that this technology will have on interventional cardiology practice. By simplifying and standardizing a complex procedure, the robot we have developed opens up new possibilities for improving the performance and safety of TAVI procedures” says Dr. Eric Sejor, co-founder and CMO of Caranx.
